NDC 50090-6089-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6089
- Requested NDC
- 50090-6089-01
- Package NDCs from labels
- 50090-6089-0, 50090-6089-1, 50090-6089-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6089-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-6089-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6089 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6089-0 | EA - Each | 50090-6089 | 1b7b2683-840d-46d0-917e-a7d77279de70 | 1 | 2022-10-06 |
| 50090-6089-1 | EA - Each | 50090-6089 | bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db5dd9d2-4f96-25d0-e053-2995a90af9dc | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c9f4923e-5625-1d4f-e053-2a95a90aabc9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db89c58f-9dd0-b6d6-e053-2a95a90ae2e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9cb3417-e8cb-13f8-e053-2a95a90a294b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ca4634a5-d8d7-48a4-e053-2995a90a0cd4 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | dac0af5d-622c-e18c-e053-2995a90a5739 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f317a597-4644-746a-e053-2995a90a807f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31b5d54-7536-4290-e053-2a95a90ac235 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f32b4a01-edea-fc85-e053-2995a90ac175 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db998119-a293-3568-e053-2995a90ac47a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dfd5b8-06a5-2728-e053-2995a90a298e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | fa15ac73-f4f6-7a6b-e053-6294a90a4f4e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31a35cb-fc54-8872-e053-2a95a90ad8e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31ba297-e042-187a-e053-2a95a90a4861 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31d987d-6836-b4a7-e053-2a95a90a8f7b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86e74e1-0d55-8d0e-e053-6394a90a07bf | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86efc89-f784-c8bb-e053-6294a90a63c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.